Editorial Office, Journal of Internal medicine, Iran
Mini Review
Treatment of Neglected Diseases with Prodrugs
Author(s): Farina Fatima*
The World Health Organization (WHO) and Médecins Sans Frontières (MSF) recently proposed a classification of diseases into three categories: global, neglected, and very neglected. The majority of pharmaceutical companies' R&D efforts are focused on global ailments such as cancer, cardiovascular disease, and mental (CNS) diseases. Millions of individuals around the world are affected by neglected diseases, but current pharmacological therapy is limited and sometimes ineffective. Furthermore, persons living in deplorable conditions with only the minimal essentials for survival are affected by extremely neglected diseases. The majority of these disorders are not included in the goals of pharmaceutical R&D projects, and hence fall outside the pharmaceutical market. Infectious diseases kill over 14 million people each year, mostly in developing nations. Only 1% of.. View More»
DOI:
10.35248/1840-4529.22.14.341
